Iztok Turel
Ljubljana, 1000, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Polynuclear Silver(I)-Quinoxaline Complex: Comprehensive Structural Characterization, Antimycobacterial Properties and DNA/BSA Binding Study.
Journal: Pharmaceutics
Published: December 29, 2025
Structure and solution biospeciation on tricarbonylrhenium(I) complexes of mercaptopyrimidines with multifaceted biological activity.
Journal: Metallomics : integrated biometal science
Published: December 05, 2025
Multimodal anticancer potential of newly synthesized palladium(II), platinum(II), and gold(III) complexes with 2-(Thiazol-2-yl)pyridine-4,5-dicarboxylate dimethyl ester.
Journal: Journal of inorganic biochemistry
Published: October 24, 2025
Dinuclear Gallium(III) Complex With 1,3-Propanediamine-N,N'-Diacetate: Structural Characterization, Antimicrobial Activity, and DNA/BSA Interactions.
Journal: Bioinorganic chemistry and applications
Published: October 18, 2024
Synergy of experimental and computational chemistry: structure and biological activity of Zn(II) hydrazone complexes.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: July 26, 2024
New insights into the effects of organometallic ruthenium complexes on nicotinic acetylcholine receptors.
Journal: Chemico-biological interactions
Published: May 31, 2024
Organometallic Ru(II), Rh(III) and Re(I) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: February 26, 2024
Silver(I) complexes with voriconazole as promising anti-Candida agents.
Journal: Journal of inorganic biochemistry
Published: February 14, 2024
Silver(I) complexes containing antifungal azoles: significant improvement of the anti-Candida potential of the azole drug after its coordination to the silver(I) ion.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: January 09, 2024
Exploring pta Alternatives in the Development of Ruthenium-Arene Anticancer Compounds.
Journal: Molecules (Basel, Switzerland)
Published: January 31, 2023
Novel Organoruthenium(II) Complex C1 Selectively Inhibits Butyrylcholinesterase without Side Effects on Neuromuscular Transmission.
Journal: International journal of molecular sciences
Published: December 16, 2022
Last Updated: 09/26/2026